Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
J Aparicio, X García del Muro, P Maroto, et al.
ESMO Open
|
November 7, 2025
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
R Dienstmann, A Vivancos, P Nuciforo, et al.
ESMO Open
|
August 27, 2021
Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study
R de Wit, C Wülfing, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2014
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
J Aparicio, P Maroto, X García Del Muro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2000
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group
J Bellmunt, V Guillem, L Paz-Ares, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 2010
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study
J Martin-Broto, A Gutierrez, X Garcia-Del-Muro, et al.
British Journal of Cancer
|
June 27, 2013
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
A Alcaraz, R González-López, J Morote, et al.
British Journal of Cancer
|
June 1, 2013
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
C de la Piedra, A Alcaraz, J Bellmunt, et al.
Revista Espanola De Cardiologia (English Ed.)
|
August 10, 2017
Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study
F Javier Sangrós, Jesús Torrecilla, Carolina Giráldez-García, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
J Aparicio, X García del Muro, P Maroto, et al.
ESMO Open
|
November 7, 2025
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
R Dienstmann, A Vivancos, P Nuciforo, et al.
ESMO Open
|
August 27, 2021
Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study
R de Wit, C Wülfing, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2014
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
J Aparicio, P Maroto, X García Del Muro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2000
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group
J Bellmunt, V Guillem, L Paz-Ares, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 2010
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study
J Martin-Broto, A Gutierrez, X Garcia-Del-Muro, et al.
British Journal of Cancer
|
June 27, 2013
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
A Alcaraz, R González-López, J Morote, et al.
British Journal of Cancer
|
June 1, 2013
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
C de la Piedra, A Alcaraz, J Bellmunt, et al.
Revista Espanola De Cardiologia (English Ed.)
|
August 10, 2017
Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study
F Javier Sangrós, Jesús Torrecilla, Carolina Giráldez-García, et al.
Page
of 14